Late last month, a Michigan company, Omni MedSci Inc. filed a lawsuit against a San Diego Company, Dexcom Inc., in the U.S. District Court for the Southern District of California with case number 3:18-cv-01653 alleging patent infringement.
The Michigan Company accused the defendant of infringing two of its patent which was assigned by U.S Patents and Trademarks Office; patent nos. ‘174 and ‘402 by their named inventor.
The plaintiff alleges that the defendants G4 and G5 mobile continuous glucose monitoring systems infringes these patents thereby causing unfair competition, confusion and demise of integrity.
The plaintiff requests a trial by jury and seeks judgment against defendant for damages from infringement of the ‘174 and ‘402 patents, injunctive relief, attorney’s fees, costs and disbursements, and all other relief to which plaintiff is entitled.
Omni MedSci Inc. Vs Dexcom Inc.
Court – U.S. District Court for the Southern District of California
Filling Date – July 20th, 2018
Case # – 3:18-cv-01653
Cause – Infringement
Case – Patent Infringement
Plaintiff Representation – William E. Thomson Jr. of Brooks Kushman PC